Sensei Biotherapeutics, Inc. (SNSE) Dividend History

Sensei Biotherapeutics, Inc. (SNSE) is a clinical-stage biopharmaceutical company focused on developing immuno-oncology therapies. The company specializes in designing vaccine and antibody-based treatments to target underlying mechanisms of cancer and improve immune response. Its proprietary platform aims to address unmet needs in cancer care through personalized and novel immunotherapies.

1405 Research Blvd, Suite 125, Rockville, MD, 20850
Phone: (240) 243-8000
Website: https://www.senseibio.com

Dividend History

Sensei Biotherapeutics, Inc. currently does not pay dividends

Company News

VISTA Inhibitor Clinical Trials Drug Approval Insight - GlobeNewswire

VISTA inhibitors are an emerging class of immunotherapeutic agents with significant potential in treating cancer and autoimmune diseases. Several companies are actively pursuing VISTA inhibitors, which offer a novel mechanism of action and broad applicability, but also face challenges such as complex development landscape and competition from existing therapies.

GlobeNewswire Inc.

Featured Companies: CRIS MRK
Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge Capital Acquisition Corp. Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) shares rose 25.8% to $0.8686 in pre-market trading. Sensei Biotherapeutics reported clinical data for SNS-101 at 2023 SITC Annual Meeting. Digital Brands Group, Inc. (NASDAQ: DBGI) shares gained 21.7% to $5.28 in pre-market trading after falling around 4% on Friday. Warrantee Inc. (NASDAQ: WRNT) rose 21.4% to $0.45 in pre-market trading after gaining 11% on Friday. RiceBran Technologies (NASDAQ: RIBT) shares climbed 21% to $0.4744 in pre-market trading after gaining 7% on Friday. POSCO Holdings Inc. (NYSE: PKX) shares jumped 18.1% to $98.51 in pre-market trading. Shares of South Korea ...

Benzinga

Featured Companies: ACXP ADCT CREV MGRX MNPR OLB SLS
Best Penny Stocks To Buy? 3 To Watch With Insider Buying In February

Insiders are scooping up these penny stocks in February. The post Best Penny Stocks To Buy? 3 To Watch With Insider Buying In February appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

PennyStocks

Featured Companies: AUR IMRA
Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q2 2021 Update

Stanley Druckenmiller’s 13F portfolio value decreased from $3.89B to $3.48B this quarter. The top three positions are at ~29% of the portfolio.

Seeking Alpha

Featured Companies: AA ABCL ABNB ACAD AMZN BKNG BLDR CAT CCCS CF CMI CPNG CVNA EXPE FCX FHN FIS FLEX FSLR FWONA FWONK GE GM GOOG GOOGL INTU JPM KBR LIN MA MAR MELI MOS MRNA MSFT NET NFLX NKTR OMF ON OPCH PANW PENN PLTR RBLX RUN S SBUX SNOW SYF TECK TMUS UBER USFD V
Sensei Biotherapeutics, Inc. (SNSE) Upgraded to Buy: Here's Why

Sensei Biotherapeutics, Inc. (SNSE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research

Page data last updated 07/23/2025 16:18:13 UTC